Sodium‐glucose co‐transporter‐2 inhibitor use and dietary carbohydrate intake in Japanese individuals with type 2 diabetes: A randomized, open‐label, 3‐arm parallel comparative, exploratory study

This study investigated the safety and efficacy of the sodium‐glucose co‐transporter‐2 (SGLT2) inhibitor luseogliflozin with differing carbohydrate intakes in Japanese individuals with type 2 diabetes (T2D). Participants were randomly assigned to 3 carbohydrate‐adjusted meals for 14 days (days 1‐14;...

Descripción completa

Detalles Bibliográficos
Autores principales: Yabe, Daisuke, Iwasaki, Masahiro, Kuwata, Hitoshi, Haraguchi, Takuya, Hamamoto, Yoshiyuki, Kurose, Takeshi, Sumita, Kiminobu, Yamazato, Hitoshi, Kanada, Shigeto, Seino, Yutaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2017
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5412941/
https://www.ncbi.nlm.nih.gov/pubmed/27990776
http://dx.doi.org/10.1111/dom.12848

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5412941/
https://www.ncbi.nlm.nih.gov/pubmed/27990776
http://dx.doi.org/10.1111/dom.12848

Ejemplares similares